HNN3.0

AIMTech

Company (SME)

Cairo, Egypt
1 profile visit

About

AI-driven research initiative focused on clinical genomics and multi-omics for precision oncology. We develop decision-support tools and predictive biomarkers using AI to support treatment response assessment and clinical validation in adult cancers. We are seeking European research, clinical, and innovation partners for collaborative projects under Horizon Europe Cluster 1

Representatives

Founder & AI Researcher (Cancer AI / Digital Health)

AIMTech

Marketplace (1)

  • Project cooperation

    Cancers AI - AI-based Multi-omics Platform for Precision Oncology

    AI-driven precision oncology platform using multi-omics for predictive biomarkers and decision support.

    • Consortium/Coordinator seeks Partners
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    Founder & AI Researcher (Cancer AI / Digital Health) at AIMTech

    Cairo, Egypt